|
 |
In Accurate Astigmatic Keratotomy Robert M. Kershner, MD,
MS, FACS
In 1994, I published my results with a technique involving
clear corneal cataract surgery and the simultaneous correction of myopia,
hyperopia, and astigmatism. I called this approach keratolenticuloplasty
to reflect the surgical modification of the cornea combined with the
correction of lenticular error by replacing the natural lens with an
IOL.1,2 My results demonstrated that surgeons could improve UCVA with the
cataract procedure. The development of new lens designs, wavefront
analysis, and even better surgical instruments and techniques has brought
the science of vision correction and neutralization of refractive error
during the cataract procedure to a new level.3-6 This article focuses on
how to combine modern refractive correction with cataract surgery. After
all, what good is an accommodating lens to a patient who must wear
spectacles for astigmatism?
SLOW ADOPTION
I have been amazed, and a bit disappointed, that cataract surgeons
as a group were slow to begin correcting their patients’ refractive
errors. After the techniques were proven and the necessary instruments
were available from enterprising, innovative manufacturers, patients still
had to wear spectacles to correct their astigmatism and presbyopia after
cataract surgery.
Ophthalmologists’ attitudes toward eliminating
or reducing patients’ need for spectacle and contact lens correction began
to change slightly when the late Svyatoslav Fyodorov, MD, introduced
radial keratotomy. Even with today’s laser technology, incisional
keratotomy still provides the simplest and most reproducible approach to
astigmatic correction during cataract surgery.
Contemporary
patients now demand and should expect unaided, clear postoperative vision.
The push for emmetropia with phakic, aphakic bifocal, and accommodative
IOLs has finally created an impetus for all surgeons to eliminate
ametropia, especially astigmatism, after cataract surgery. Eighty-nine
percent of patients can achieve adequate visual acuity without spectacles
for most tasks using today’s surgical techniques.4
PREOPERATIVE EVALUATION AND SURGICAL
PLANNING Strategy
In all patients, surgeons should fully correct the
sphere for distance and eliminate more than 0.75D of astigmatism with a
single-incision keratotomy that can also act as the IOL’s insertion site.
The goal should be full correction or a slight undercorrection of the
cylinder, never an overcorrection or shift in the cylinder’s axis. To
avoid the possibility of error, I create a preoperative surgical
plan.
Limbal Relaxing Incisions
The term limbal relaxing incision (LRI) is a misnomer. The
flattening incisions made in the cornea are neither relaxing nor limbal.
Where one makes the incision is just as important as how one makes it.
Prior to surgery, I note in the chart the position of the patient’s
steepest corneal meridian (I recommend consulting a worksheet). The
surgeon should carefully evaluate the patient’s preoperative astigmatism
and take a topographic map into the OR. Corneal incisions can consistently
and predictably alter the corneal curvature. First described by Spencer
Thornton, MD, of Nashville, Tennessee, one of the early American pioneers
in refractive keratotomy, all transverse or arcuate corneal incisions will
flatten the cornea in the meridian in which they are placed by acting as
if tissue were added to the keratotomy site.
The Best Flattening Incision
I have long championed a single, small, arcuate incision (AK) on
near clear cornea at an optical zone of approximately 10mm. Small
incisions avoid trouble, because their flattening effect occurs only in
the meridian where they are placed while the cornea becomes steeper 90º
away through a process known as coupling. If a single incision is
insufficient, I simply pair it with another cut on the opposite meridian.
Rather than flatten only the steep meridian, large incisions have a more
global effect, and they increase the potential for irregular astigmatism
and a change in the overall corneal power.
How do arcuate
astigmatic incisions differ from LRIs? Because they are placed far
peripherally in the cornea at the scleral limbus and farthest from the
optical center of the eye, LRIs have a less flattening effect for a given
length. As a result, they must be large to substantially affect the
corneal curvature. When LRIs exceed 120º of arc, especially if they are
placed nasally or temporally, they damage the corneal nerves at that
location and create problems with dry eye and healing. Smaller, arcuate
incisions (usually 3mm) that closely follow the natural corneal curvature
produce a greater effect with less cutting and little risk compared with
LRIs. I recommend following a published nomogram, using the
appropriate tools, and making the incision deep enough (at least 85% to
95% corneal thickness) to have a permanent effect. The results will be
highly predictable (Figure 1).
INSTRUMENTS FOR AK
I have been pleased to see the large number of AK instruments now
available from numerous manufacturers. When performing AK, I administer
topical anesthesia so that the patient can fixate on the OR microscope’s
light. For safety’s sake, I use a Thornton-style ring to fixate the globe.
I mark the location of the AK on the steepest meridian using one of the
astigmatic markers (Rhein Medical, Inc., Tampa, FL) I designed. For
surgeons who prefer the sharpness of the diamond blade and have the budget
and staff to purchase and maintain one, I would recommend the Seibel LRI
Diamond Knife (Rhein Medical, Inc.), the Kershner AK blade (Diamatrix
Ltd., The Woodlands, TX), or the Thornton Arc T Blade (Mastel Precision,
Inc., Rapid City, SD). Diamond blades are best for a smooth, reproducible,
full-depth incision of greater than 85% to 90%. For diamond-like quality
in a disposable product, I have been impressed with the BD Atomic Edge
Blade (BD Ophthalmic Systems, Waltham, MA), which is made from silicon
semiconductor material. The products I have mentioned are only a sampling
of the many available, and more are developed every day.
I suggest
taking a pachymetry reading at the site of the AK and then setting the
blade to 100% of this measurement. The most common cause of inadequate
correction is an insufficient depth to ensure flattening. If a pachymeter
is not available, the ophthalmologist may use a preset blade or manually
set the blade to between 600 and 650µm.
CONCLUSION
Investing time and money in learning AK, a procedure that is
usually not reimbursed, repays the surgeon many times over with better
outcomes, a benefit for patients as well. As new IOL technologies that
restore accommodation and enhance visual function gain increasing
acceptance among ophthalmologists, the need to deliver clear UCVA becomes
more important than ever. This goal is within the reach of every
refractive cataract surgeon.
Published nomograms are available at
http://www.bd.com/ophthalmology and at
http://www.oasismedical.com.
Robert M. Kershner, MD, MS, FACS, is
President and CEO of Eye Laser Consulting in Boston. He states that he
holds no financial interest in any product or company mentioned herein.
Dr. Kershner may be reached at
kershner@eyelaserconsulting.com.
1. Kershner RM. Refractive
Keratotomy for Cataract Surgery and the Correction of Astigmatism.
Thorofare, NJ: Slack, Inc.; 1994.
2. Kershner RM.
Keratolenticuloplasty. In: Gills JP, Sanders DR, eds. Surgical Treatment
of Astigmatism. Thorofare, NJ: Slack, Inc.; 1994: 143-155.
3.
Kershner RM. Keratolenticuloplasty: arcuate keratotomy for cataract
surgery and astigmatism. J Cataract Refract Surg.
1995;21:274-277.
4. Kershner RM. Clear corneal cataract surgery and
the correction of myopia, hyperopia and astigmatism. Ophthalmology.
1997;104:381-389.
5. Kershner RM. Optimizing the refractive outcome
of clear cornea cataract surgery. In: Agarwal S, Agarwal A, Agarwal A,
eds. Phaco, Phakonit and Laser Phaco—a Quest for the Best. Dorado,
Republic of Panama: Highlights of Ophthalmology; 2002: 85-104.
6.
Kershner RM. Refractive keratotomy and the toric IOL for the correction of
astigmatism in clear cornea cataract surgery. In: Gills J, ed. A Complete
Surgical Guide for Correcting Astigmatism. Thorofare, NJ: Slack, Inc.;
2002: 49-64.
The Staar Toric IOL David F. Chang, MD
To
address preexisting astigmatism at the time of cataract surgery, I prefer
limbal relaxing incisions (LRIs) because they are quick and virtually free
of complications.
There are two categories of patients, however,
in whom LRIs are less effective and for whom I have been using a toric IOL
instead. One is younger cataract patients (< 60 years) with more than
2.00D of astigmatism, because a younger age significantly reduces the
attainable effect from incisional keratotomy. The second group includes
patients with the highest amounts of astigmatism (eg, > +3.00D). LRIs
are much less predictable in these eyes, and, for against-the-rule
cylinder, I want to avoid combining my temporal clear corneal incision
within a large, temporal LRI. This article highlights data on and my own
experience with the Staar Toric IOL (Staar Surgical Company, Monrovia,
CA).
BACKGROUND
The FDA approved the Staar silicone plate-haptic toric IOL in
November 1998, and it remains the only available toric IOL in the US
today. The IOL is available in two astigmatic powers; the +2.00D toric
lens corrects 1.50D of keratometric astigmatism, and the +3.50D toric
power corrects approximately 2.25D at the spectacle plane. I exclusively
use the +3.50D cylindrical correction to address those cases where LRIs
are less effective. The Staar Toric IOL is also available in two different
lengths: the 10.8-mm–long TF model, which was the original FDA-studied
design, and the 11.2-mm TL model, released in 1999, for spherical powers
of ≤ 23.50D.
ROTATION
A primary risk with any toric IOL is postoperative off-axis
rotation. Any misalignment of the toric axis decreases the amount of
astigmatism reduced. With 10º of axis deviation, approximately one-third
of the effect is lost. With 20º of axis deviation, approximately
two-thirds of the effect is lost. Misalignment of the lens greater than
30º produces a net worsening of astigmatism. With the Staar Toric IOL,
late rotation has not been a problem, suggesting that, once the capsular
bag has fully contracted, the torsional fixation is permanent. Early
postoperative rotation of the TF model has been a significant issue,
however.
According to FDA study data, 24% of the toric IOLs ended
up more than 10º off axis: 12% were >20º off; 8% were >30º off; and
5% were >45º off axis. The FDA study evaluated only the shorter 10.8-mm
TF lens. Subsequently, a number of published clinical studies1-4 of the
Staar Toric IOL confirmed a significant incidence of more than 10º to 15º
of rotation postoperatively with the shorter TF model (Table 1).
Staar Surgical Company’s release of the longer TL model was an
effort to decrease early rotation. When the longer toric IOLs became
available in 1999, I undertook my own study of the rotational stability of
this model.5 All of the earlier published reports had studied the TF
model, which was the only available model at that time. At the 2003 ASCRS
meeting, I updated my results from an expanded study of 90 consecutive
Staar Toric IOL implantations.6 All 90 implants were with the higher
+3.50D toric power. Eighty were the longer TL IOLs, and 10 were TF IOLs in
powers > 24.00D (where the TL model is not available).
The IOLs
exhibited excellent rotational stability. In the 80 consecutive TL toric
implants, 73% were within 5º, 89% were within 10º, and 96% were within 15º
of the target axis. These results represented a significant improvement
compared with both the FDA data and the data from previously published
series1-4 in which the shorter TF model was used. My repositioning rate
was 2.5% (two of 80 lenses) with the longer TL model and 3.3% overall (one
of 10 TF models).
TIPS
I continue to employ the same surgical guidelines for implanting
the Staar Toric IOL that were used during my study.5,6 I always use the
longer TL model if it is available (power < 23.50D). I inflate the
capsular bag with a cohesive viscoelastic, because dispersive
viscoelastics render the silicone IOL surface more slippery. To maximize
the contact between the IOL and the posterior capsule, I remove any
viscoelastic trapped behind the optic with the I/A handpiece. I try not to
overly inflate the eye, because leaving the globe somewhat softer probably
allows the flaccid capsular bag to collapse around the IOL more quickly.
I make an astigmatically neutral, temporal, clear corneal incision
and employ topical anesthesia without postoperative patching or shields.
While the patient is sitting upright on the operating table just prior to
surgery, I dot the limbus at the 6-o’clock position with a skin-marking
pen. Beneath the microscope, a Mendez-style degree gauge facilitates the
orientation of two limbal ink marks that identify the desired axis. After
implanting the IOL, I can align its axis marks with these ink marks
(Figure 2) and double check them against the preoperative notes or
chart.
Any repositioning procedure should be performed within the
first postoperative week. Once the capsular bag fully contracts, rotating
the IOL requires greater force, which might increase the chance of tearing
the capsular bag or zonules. Plate haptic IOLs should never be implanted
in the sulcus or in the presence of a torn capsulorhexis or posterior
capsule.
CONCLUSION
Toric IOLs are an excellent complement to corneal astigmatic
incisions, and they are particularly useful for patients with very high
amounts of keratometric cylinder. Early clinical studies indicate
excellent rotational stability with the toric Acrysof IOL (Alcon
Laboratories, Inc., Fort Worth, TX) as could be expected due to its tacky
acrylic material. Because of its advantages over a plate haptic silicone
design, I believe that the new Acrysof will become the toric IOL of choice
once approved by the FDA. For the past 5 years, however, I believe that
the Staar Toric IOL has been grossly underutilized in part because of
ophthalmologists’ misconceptions about its true rate of rotation. Proper
surgical technique and the use of the longer lens model have provided
excellent rotational stability and efficacy. Until a better toric IOL
comes along, the Staar Toric IOL is an excellent and viable option for
cases in which LRIs are least effective.
David F. Chang, MD, is
Clinical Professor of Ophthalmology at the University of California, San
Francisco and is in private practice iin Los Altos, California. He states
that he holds no financial interest in any product or company mentioned
herein. Dr. Chang may be reached at (650) 948-9123;
dceye@earthlink.net.
1. Sun XY, Vicary D, Montgomery P, Griffiths
M. Toric intraocular lenses for correcting astigmatism in 130 eyes.
Ophthalmology. 2000;107:1776-1781; discussion by Kershner RM:
1781-1782.
2. Ruhswurm I, Scholz U, Zehetmayer M, et al.
Astigmatism correction with foldable toric intraocular lens in cataract
patients. J Cataract Refract Surg. 2000;26:1022-1027.
3. Leyland M,
Zinicola P, Bloom P, Lee N. Prospective evaluation of a plate haptic toric
intraocular lens. Eye. 2001;15:202-205.
4. Till JS, Yoder PR,
Wilcox TK, Spielman JL. Toric intraocular lens implantation: 100
consecutive cases. J Cataract Refract Surg. 2002;28:295-301.
5.
Chang DF. Early rotational stability of the longer Staar Toric IOL–50
consecutive (TL) IOLs. J Cataract Refract Surg. 2003;29:935-940.
6. Chang DF. Early rotational stability of the longer Staar Toric
IOL: 70 consecutive cases. Paper presented at: The ASCRS/ASOA Symposium on
Cataract, IOL and Refractive Surgery; April 14, 2003; San Francisco,
CA. New-Generation Toric IOL Warren E. Hill, MD
At present,
cataract surgeons have only two options for correcting significant corneal
astigmatism: limbal relaxing incisions (LRIs), or a plate haptic toric
intraocular lens.
Of course, LRIs remain an old and trusted
techniques, which work well to lessen low magnitudes of corneal
astigmatism. They are easy to perform and generally do not require a great
deal of precision. However, LRIs cannot be used in all situations.
Although the first-generation toric IOL gave us another useful option, it
also presented some challenges—mostly with rotational stability and a
limited power range. The next generation of toric IOLs offers refinements
that elegantly address these concerns.
The Acrysof Toric IOL (Alcon
Laboratories, Inc., Fort Worth, TX), which is currently undergoing FDA
clinical trials, is based on the familiar SA60 single-piece acrylic
platform (Alcon Laboratories, Inc.). Aside from an expanded power range
and excellent rotational stability, this newest addition to our surgical
armamentarium offers another refinement to its use: the surgeon will now
be able to take into account the astigmatism induced by the cataract
surgical wound (Figure 3). This approach results in an enhanced prediction
of the true axis of postoperative corneal astigmatism and a more accurate
prediction of the cylindrical power required.
THE VALUE OF VECTOR ANALYSIS
Any measurement that has both magnitude and direction can be
considered a vector. For example: +2.00D of corneal astigmatism at an axis
of 135º would be a vector quantity. This measurement becomes important
when you stop to consider the fact that both the axis and the magnitude of
corneal astigmatism prior to cataract surgery are often different than
after cataract surgery. This is especially true if the incision is large
or is placed superiorly.
Although many surgeons no longer think
about modern clear corneal cataract incisions’ inducing astigmatism, for
most corneal incisions, the vector of the corneal wound invariably changes
the vector of the corneal astigmatism, depending on the location, size,
and architecture. If the toric IOL power selection and axis of placement
are solely based on preoperative keratometry, an astigmatic angular error
may occur, even in the absence of IOL rotation. Those who have implanted
first-generation toric IOLs, where the effect of the wound is completely
ignored, are all too familiar with this finding, as both the axis and the
amount of refractive astigmatism often do not match what would be
expected.
Because corneal astigmatism can be viewed as a vector,
and the astigmatism induced by the corneal wound is also a vector, these
two vectors can be added together. Just as a pilot may be required to
change power and course direction to compensate for the wind, the surgeon
may also be required to calculate a new toric IOL power and a new toric
IOL axis to compensate for astigmatic changes induced by the cataract
wound.
For example, a cataract surgery patient has a low degree of
astigmatism, say +1.25D, to be corrected by a toric IOL, with the steep
axis at 135º. The surgeon makes either a single- or double-plane temporal
clear corneal incision at 180º, which induces approximately 0.50D of
steepening at 90º. Although this change may not appear significant,
ignoring the resultant axis shift will produce an angular error of
approximately 0.50D at the corneal plane and approximately 0.75D at the
plane of the capsular bag. In other words, the toric power of the IOL
would be off by 0.75D.
As another example, a cataract patient has
+2.00D of corneal astigmatism to be corrected by a toric IOL, with the
steep axis at 135º. The surgeon makes a scleral tunnel incision at 90º,
which, for this particular surgeon, typically induces 0.75D of steepening
at 180º. Even though the amount of corneal astigmatism has not
significantly changed, ignoring the axis shift induced by this incision
would produce a residual angular error of approximately 0.75D at the
corneal plane and approximately 1.00D at the plane of the capsular bag. In
other words, the toric power of the IOL would be off by +1.00D.
Not
only will the Acrysof Toric IOL be on a rotationally stable platform, but
also for the first time, companion software will be made available to
surgeons to more precisely calculate the new resultant axis and power of
astigmatism, based on their individual incision data.
My partner,
Neal Nirenberg, MD, and I were investigators for the recently completed
phase III FDA study of 500 eyes implanted with this toric technology. The
data from this study revealed exceptional rotational stability with 83% of
implantations remaining within 5º of the target axis. The 100-day data
from this same study showed that approximately 80% of patients had less
than 0.75D of residual postoperative astigmatism, and close to 70% had
less than 0.50D of residual postoperative astigmatism. These results
confirmed our initial impression that the addition of vector analysis as a
further refinement to toric IOL power calculations is a valuable
exercise.
FINAL THOUGHTS
In summary, this newest generation of toric IOLs exhibits
excellent rotational stability and can be used with companion vector
analysis software to further optimize refractive accuracy. This approach
requires careful preoperative keratometry and an awareness of the amount
of astigmatism induced by each surgeon’s typical incision. The new Acrysof
Toric IOL will be the first lens to employ such a strategy.
Warren
E. Hill, MD, FACS, is Medical Director of East Valley Ophthalmology in
Mesa, Arizona. He has worked as a consultant in the area of IOL
mathematics for Alcon Laboratories, Inc. Dr. Hill may be reached at (480)
981-6130; hill@doctor-hill.com.
Bioptics and Refractive IOLs John Doane, MD,
FACS
What is bioptics, why do we employ this technique, and how do
we use it in a planned and an unplanned fashion? Many surgeons currently
use bioptics to achieve emmetropia, whether with a combination of a
refractive IOL and a conventional IOL in sulcus piggyback fashion or,
alternatively, a refractive IOL (phakic or pseudophakic) combined with
laser vision correction to achieve the refractive target.
PLANNED BIOPTICS
During a planned bioptics procedure, the surgeon may first implant
a phakic refractive lens or a pseudophakic lens followed by corneal laser
vision correction, or he may place a pseudophakic lens and follow this
with a conventional lens in sulcus piggyback fashion. Unplanned bioptics
is considered to be the enhancement of any refractive or pseudophakic IOL
with a laser procedure or sulcus piggyback IOL. For example, the treatment
of a patient who has 5.00D of corneal astigmatism requires the combination
of two different procedures (eg, combination of a toric IOL and limbal
relaxing incision[s] or a combination of a toric or conventional IOL and
corneal laser vision correction).
An early example of planned
bioptics is what occurred in the early 1990s with automated lamellar
keratoplasy (ALK) combined with radial keratotomy. Typically, ALK for
myopia would leave residual myopia of 1.00 to 3.00D. After 3 months or so,
the surgeon could treat the patient with radial keratotomy to achieve near
emmetropia. During the past 5 years, international ophthalmologists who
have been implanting phakic IOLs have combined the lenses with corneal
laser vision correction to treat any residual spherical refractive error
or preexisting cylindrical error. In the past year or so, I have used the
Crystalens (Eyeonics, Inc., Aliso Viejo) in bioptics fashion with either
conventional IOLs in the ciliary sulcus or laser vision correction to
treat residual spherical error or preexisting corneal cylindrical
error.
TREATMENT OPTIONS
In a planned bioptics technique, a surgeon can implant the
Crystalens or multifocal IOLs bilaterally and wait up to 3 months to allow
the corneoscleral wound to heal before performing a lamellar procedure,
such as LASIK, that raises the IOP. The surgical interval in these cases
is approximately 12 to 14 weeks. I term this interval refractive purgatory
because the surgeon must fit the patient with spectacles or contact lenses
to make his vision functional for work, driving, and outside activities.
Alternatively, a surgeon can create lamellar flaps, implant accommodative
or multifocal lenses in both eyes, wait 4 weeks for the lamellar flap and
the corneoscleral wounds to settle to refractive stability, and then lift
the corneal flap and ablate the residual refractive error with an excimer
laser. Lastly, if a surgeon prefers surface ablative techniques he can
implant the IOL and allow for sufficient postoperative refractive
stability (3 to 4 weeks) and then proceed with surface excimer laser
treatment.
SULCUS PIGGYBACK IOLs
Cataract/refractive surgeons are commonly faced with a refractive
or cataract case that requires an accommodative IOL power that is outside
the available range, or surgeons need to adjust for a refractive surprise.
In some of these cases, I will place a piggyback IOL in the ciliary
sulcus. I have, been using the Staar AQ5010V (Staar Surgical Company,
Monrovia, CA), which comes in the range of -4.00 to +4.00D, and the
Clariflex IOL (Advanced Medical Optics, Inc., Santa Ana, CA), which comes
in low dioptric powers in 0.50D increments. I use the AQ5010V or the
Clariflex low plus lenses for patients who are left with lower amounts of
hyperopic refractive error (planned or unplanned). I allow for a 1-month
lapse in between implanting the sulcus piggyback lens to ensure a stable
refraction. Other surgeons may opt for excimer hyperopic ablation or
conductive keratoplasty to achieve emmetropia. Personally, I prefer the
refractive stability of an IOL.
A typical scenario in my experience
is that a patient presents with a large amount of corneal cylinder or
requires an IOL power that is not available. For example, the Crystalens
is available in powers ranging from +10.00D to +33.00D, but some patients
may need a +2.00, +35.00, or even a +38.00D lens. For highly myopic and/or
astigmatic patients, I create bilateral corneal flaps, bilaterally implant
the Crystalens, wait 4 weeks, lift the flap, and then ablate any residual
refractive error. Alternatively, for extremely myopic patients, I place
negative power IOLs in the sulcus to achieve near emmetropia and take
advantage of accommodative IOL technology in the capsular bag. To date, I
have not found that an IOL in the sulcus negatively affects the
accommodative ability of the Crystalens. Conversely, in cases of very
short eyes with high hyperopia, I may implant a +33.00D Crystalens
followed by an appropriately powered plus lens in the ciliary sulcus to
achieve near emmetropia.
WHY GO TO THE TROUBLE OF BIOPTICS?
In cases as described earlier, the only option for individuals
with refractive errors that are far from the mean refractive error of the
general population is to undergo more than one surgical procedure. From
this viewpoint, bioptics is the only modality to allow this patient
population the opportunity to take advantage of the latest ophthalmic
device technologies. Ideally, a single procedure would suffice, but at
present the surgeon and patient must accept the reality of the status quo
and plan appropriately to achieve the desired goals. Bioptics will
likely continue to be a process that certain patients can take advantage
of in a planned or unplanned fashion. The important point to remember is
that refractively minded patients expect nearly perfect vision, which
equates to near emmetropia; therefore, the ophthalmic surgeon interested
in refractive IOL surgery will have to be well versed in the role and
benefits of bioptic techniques.
John F. Doane, MD, FACS, is in
private practice with Discover Vision Centers in Kansas City, Missouri,
and is Clinical Assistant Professor for the Department of Ophthalmology,
Kansas University Medical Center. Dr. Doane is a co-course director of
Eyeonics Crystalens certification courses and has been compensated by
Eyeonics for research overhead during the FDA clinical investigation of
the Crystalens. Dr. Doane may be reached at (816) 478-1230;
jdoane@discovervision.com. |
|
|